Miguel Gómez Álvarez/LinkedIn
Jun 15, 2026, 13:51
Miguel Gómez Álvarez: Navigating the Complexities of Erythrocytosis and the Role of PIEZO1
Miguel Gómez Álvarez, Hematologist at Department of Hematology and Hemotherapy, Hospital Clínico San Carlos, Madrid, Spain, shared a post on X:
“Increasingly prevalent in our consultations… erythrocytosis, its complex differential diagnosis, PIEZO1, and the doubts about how to manage it at EHA 2026.
How do we categorize them and when to perform phlebotomies?”
Stay updated with Hemostasis Today.
-
Sep 28, 2026, 11:26Andra Tocarciuc: Immune TTP in 2026 – Moving Toward Plasma Exchange–Free Care
-
Sep 28, 2026, 11:13Nathan Pennell: 3 Questions That Matter for the Next Multiple Myeloma Treatment
-
Sep 28, 2026, 11:00Oren Rom: Connecting Amino Acid and Lipid Metabolism in MASH
-
Sep 28, 2026, 10:38Dawn Rotellini: Advocating for Women and Girls With Bleeding Disorders
-
Sep 28, 2026, 10:18Neha Rastogi Panda: Empowering Young Women Through Health Awareness
-
Sep 28, 2026, 10:16S.0 MIKAYE – Hypertension in Pregnancy From Diagnosis to Management
-
Sep 28, 2026, 09:45Emma Groarke: The 3rd International VEXAS Conference in Milan
-
Sep 28, 2026, 09:36Iman Alshamsi: Thrombophilia Workup and PNH Screening When Testing Matters
-
Sep 28, 2026, 09:25Emadullah Raidullah: Thrombophilia Workup and PNH Screening When Testing Matters